Singapore markets closed

Cara Therapeutics, Inc. (CARA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.6719+0.0007 (+0.10%)
At close: 04:00PM EDT
0.6720 +0.00 (+0.01%)
After hours: 07:58PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
16,938
20,968
41,867
23,028
135,082
-
Cost of revenue
4,204
6,174
7,266
0
0
-
Gross profit
12,734
14,794
34,601
23,028
135,082
-
Operating expenses
Research development
106,140
108,510
91,879
82,701
107,851
-
Selling general and administrative
27,573
27,649
30,129
29,285
21,749
-
Total operating expenses
133,844
136,289
122,136
112,111
129,697
-
Operating income or loss
-121,110
-121,495
-87,535
-89,083
5,385
-
Interest expense
2,586
604
0
0
-
-
Total other income/expenses net
1,152
3,586
2,061
642
2,334
-
Income before tax
-122,544
-118,513
-85,474
-88,441
7,719
-
Income tax expense
-
-
0
0
-691
-816
Income from continuing operations
-122,544
-118,513
-85,474
-88,441
8,410
-
Net income
-122,544
-118,513
-85,474
-88,441
8,410
-
Net income available to common shareholders
-122,544
-118,513
-85,474
-88,441
8,410
-
Basic EPS
-2.15
-2.19
-1.59
-1.74
0.18
-
Diluted EPS
-2.15
-2.19
-1.59
-1.74
0.18
-
Basic average shares
53,970
54,149
53,654
50,719
47,413
-
Diluted average shares
53,970
54,149
53,654
50,719
47,915
-